🔸 Introduction: Mantle cell lymphoma affects the blood and understanding it can aid in symptom management and treatment.
🔸 What is MCL?: Often termed MSL, it's a form of non-Hodgkin lymphoma in white blood cells. Around 70 non-Hodgkin lymphomas exist, with MSL identified as such by WHO in 1992.
🔸 Prevalence: MCL accounts for roughly 6% of all non-Hodgkin lymphoma cases. Annually, about 4,200 people are diagnosed with MCL in the U.S., making it relatively rare.
🔸 Causes: The exact cause remains unidentified, but mutations in the B lymphocyte or B cell might play a role, causing them to produce excessive protein and lead to lymphoma.
🔸 Types:
Classical MCL or nodal MCL is more common and aggressive, primarily affecting lymph nodes.
Leukemic, non-nodal MCL affects the bone marrow, blood, and spleen and is less aggressive.
🔸 Symptoms: Initially, MCL might be symptomless. However, symptoms such as severe night sweats, fever, significant weight loss, energy deficiency, swelling, gastrointestinal issues, and back pain may manifest over time.
🔸 Treatment Options:
Chemotherapy: Utilizes drugs to eliminate cancer cells.
Immunotherapy: Boosts the body's immune system, often paired with chemotherapy.
Stem Cell Transplant: Replaces cancerous blood cells with healthy stem cells.
Targeted Therapies: Focus on specific proteins promoting cancer, often causing fewer side effects than chemotherapy.
Clinical Trials: Patients should consider inquiring about these to access new treatments.
Stay informed and consult a healthcare professional for a comprehensive understanding and guidance on Mantle Cell Lymphoma.
For more information about Mantle Cell Lymphoma clinical trial options, check out the link below.
[ Ссылка ]
Comment on this video and subscribe to our channel!
At Massive Bio, we believe all cancer patients deserve equal access to leading edge therapies and new-emerging clinical trials, regardless of where they live or their ability to pay.
Contact Us:
Phone: +1 844-627-7246
Email: support@massivebio.com
Visit our website to learn more:
[ Ссылка ]
